Group 1 - The company held its fifth board meeting on November 18, 2025, where all seven directors attended and voted on the agenda [2][5][3] - The board approved the acquisition of 70% equity in Jiangsu Heyutai Chemical Co., Ltd. for a cash consideration of 153.86 million yuan, funded by self-owned funds and bank loans [4][11][12] - The acquisition will allow Jiangsu Heyutai to become a wholly-owned subsidiary of the company, enhancing its product value chain and market position [11][15] Group 2 - Jiangsu Heyutai, established in June 2013, specializes in agricultural chemical products and has a registered capital of 120 million yuan [17][25] - The acquisition price was determined based on an asset appraisal that valued 100% of Jiangsu Heyutai's equity at 285.30 million yuan, with a 4.22% increase in value [28][30] - The company aims to leverage Jiangsu Heyutai's existing product lines and customer resources to enhance its operational efficiency and market reach [46][47] Group 3 - The transaction does not constitute a related party transaction or a major asset restructuring, and it does not require shareholder approval [12][16] - The company plans to implement measures to improve Jiangsu Heyutai's performance, which has shown signs of recovery after a period of losses [46][47] - The board's decision was supported by the strategic committee, ensuring compliance with legal and regulatory requirements [6][3]
浙江巍华新材料股份有限公司 第五届董事会第二次会议决议公告